- Home
- NXL vs BODI Comparison
NXL vs BODI Comparison
Compare NXL & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- BODI
- Stock Information
- Founded
- NXL 2010
- BODI 1998
- Country
- NXL United States
- BODI United States
- Employees
- NXL N/A
- BODI N/A
- Industry
- NXL Medical Specialities
- BODI Industrial Machinery/Components
- Sector
- NXL Health Care
- BODI Industrials
- Exchange
- NXL Nasdaq
- BODI Nasdaq
- Market Cap
- NXL 24.2M
- BODI 28.3M
- IPO Year
- NXL 2022
- BODI N/A
- Fundamental
- Price
- NXL $1.19
- BODI $3.69
- Analyst Decision
- NXL Strong Buy
- BODI Strong Buy
- Analyst Count
- NXL 1
- BODI 3
- Target Price
- NXL $5.00
- BODI $10.67
- AVG Volume (30 Days)
- NXL 126.6K
- BODI 35.2K
- Earning Date
- NXL 05-13-2025
- BODI 05-14-2025
- Dividend Yield
- NXL N/A
- BODI N/A
- EPS Growth
- NXL N/A
- BODI N/A
- EPS
- NXL N/A
- BODI N/A
- Revenue
- NXL $131,065.00
- BODI $371,113,000.00
- Revenue This Year
- NXL $79.59
- BODI N/A
- Revenue Next Year
- NXL $334.65
- BODI N/A
- P/E Ratio
- NXL N/A
- BODI N/A
- Revenue Growth
- NXL N/A
- BODI N/A
- 52 Week Low
- NXL $0.53
- BODI $3.38
- 52 Week High
- NXL $4.49
- BODI $9.50
- Technical
- Relative Strength Index (RSI)
- NXL 30.13
- BODI 38.64
- Support Level
- NXL $1.18
- BODI $3.38
- Resistance Level
- NXL $1.24
- BODI $3.75
- Average True Range (ATR)
- NXL 0.07
- BODI 0.42
- MACD
- NXL 0.02
- BODI -0.02
- Stochastic Oscillator
- NXL 18.18
- BODI 13.09
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.